SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Dov Pharmaceutical, Inc - DOVP
An SI Board Since April 2002
Posts SubjectMarks Bans Symbol
172 28 0 DOVP
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
72Uh Oh. Start of DOV Pharmaceutical's Phase III Trial of Ocinaplon Placed onkeokalani'nui-10/2/2003
71Oh that's nice! (I think.) It is isn't it? Looks good from here. Tookeokalani'nui-9/10/2003
70DOV Pharmaceutical Announces Positive Phase III Results for Bicifadine, Its Novescaram(o)uche-9/10/2003
69CIBC Plans Sale Of DOV Shares It Received After IPO Tuesday July 29, 11:40 am ETscaram(o)uche-7/29/2003
68Dow Jones story out saying that CIBC is going to sell their shares, held from thscaram(o)uche-7/29/2003
67Been thinking that myself. With indiplone a slam dunk, bicifidne P3 likely to bkeokalani'nui-7/9/2003
66monster stock. (eom)scaram(o)uche-7/9/2003
65DOV Pharmaceutical, Inc. Announces $15 Million Equity Investment By OrbiMed Advikeokalani'nui-7/2/2003
64Sounds to me that there is a DDI issue that requires clarification, hence the adBiotech Jim-5/20/2003
63<i>Anything sound not quite right about the order and timing of these studkeokalani'nui-5/20/2003
62Study Shows Nighttime Dosing of Biovail's Cardizem LA May Be More Effective keokalani'nui-5/19/2003
61<i>4/8/2003 Model Portfolio addition Dr. Ron Garren Chief BiotechnologWard Knutson-4/8/2003
60DOV Pharmaceutical, Inc. Re-Acquires DOV Diltiazem Patent from Biovail Laboratorkeokalani'nui-4/1/2003
59HACKENSACK, N.J., March 28 /PRNewswire-FirstCall/ -- DOV Pharmaceutical, Inc. (Nnigel bates-3/28/2003
58HACKENSACK, N.J., March 26 /PRNewswire-FirstCall/ -- DOV Pharmaceutical, Inc. (Nnigel bates-3/26/2003
57>>HACKENSACK, N.J., March 20 /PRNewswire-FirstCall/ -- DOV Pharmaceutical,tuck-3/20/2003
56Merck Drops Development of Anxiety Drug Thursday February 6, 3:51 pm ET NEW YOkeokalani'nui-2/6/2003
55>>HACKENSACK, N.J., Dec. 23 /PRNewswire-FirstCall/ -- DOV Pharmaceutical, tuck-12/23/2002
54See Message 18358814 et seq.keokalani'nui-12/20/2002
53DOV Pharmaceutical Announces Extended Royalty Period for Novel Insomnia Drug Andnigel bates-12/20/2002
52DOV Pharmaceutical Announces Phase III Trial Initiation For Its Novel, Non-Narcomopgcw-12/20/2002
51hits $5 pre-market. thought it was never going to happen...... finance.yahoo.cscaram(o)uche-11/14/2002
50Message 18224393 A good question is How big is this pool? >>Several custkeokalani'nui-11/12/2002
49I guess not sufficiently material to webcast. <i>DOV Pharmaceutical, Inc.keokalani'nui-11/6/2002
48Great. Not. Now we see the effect of lockup expiration..... volume availablscaram(o)uche-11/4/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News